Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
FDA Seeks Public Views on Proposed 510(k) Plans
August 01, 2011
The FDA expects 'strong public interest' regarding IOM's recommendations to make big changes to device review processes.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register quickly here for free access.
New to GenomeWeb? Register quickly here for free access.
Related Stories
- IOM Report Urges FDA Shift from 510(k) Program
August 1, 2011 / GenomeWeb Daily News - IoM to Study Effectiveness of FDA's 510(k) Review Process for Medical Devices
September 30, 2009 / Pharmacogenomics Reporter - Quidel Expands Market for Flu Assay with Second Platform Approval
March 22, 2012 / PCR Insider - Idaho Technology Files for FDA Clearance of Expanded FilmArray Respiratory Panel
February 2, 2012 / PCR Insider - Dx Focus: Quidel Gets FDA OK for First Pair of Molecular Tests
January 5, 2012 / PCR Insider